A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

Pfizer PFE has committed significant resources for the development of treatments in the fields of oncology, internal medicine ...

Pfizer's recent trial termination makes it yet another company facing challenges with CD47 studies in oncology.

The House Judiciary Committee subpoenaed a former Pfizer Inc. executive, demanding he address allegations of deliberately ...

Chairman Jim Jordan subpoenaed former Pfizer executive Dr. Philip Dormitzer for an investigation into delayed COVID-19 ...

House Judiciary Chair Jim Jordan subpoenaed Dr. Philip Dormitzer after he refused to testify in the 2020 vaccine delay probe, ...

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...

Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies, ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

XtalPi has accrued a number of Big Pharma partners over the years, including Eli Lilly, which struck a $250 million deal in 2023 to use XtalPi’s tech to identify potential drug candidates that Lilly ...

(Reuters) -The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily ...